FN2 Earnings Intelligence
Elanco Animal Health Incorporated financials (quarterly)
Elanco Animal Health Incorporated (ELAN) Key Stats (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $487 | $539 | $505 | $428 | $530 |
| + Debt | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - |
| Revenue | $1,193 | $1,241 | $1,137 | $1,371 | $1,368 |
| % Growth | - | - | - | - | - |
| Gross Profit | $684 | $713 | $607 | $785 | $798 |
| % Margin | 57.3% | 57.5% | 53.4% | 57.3% | 58.3% |
| EBITDA | - | - | - | - | - |
| % Margin | - | - | - | - | - |
| Net Income | $67 | $11 | -$34 | $57 | $54 |
| % Margin | 5.6% | 0.9% | -3.0% | 4.2% | 3.9% |
| Diluted EPS | $0.13 | $0.02 | -$0.07 | $0.11 | $0.11 |
| % Growth | - | - | - | - | - |
| Operating Cash Flow | -$4 | - | - | $13 | - |
| CapEx | $65 | - | - | $51 | - |
| Free Cash Flow | -$69 | - | - | -$38 | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue | $1,193 | $1,241 | $1,137 | $1,371 | $1,368 |
| Gross Profit | $684 | $713 | $607 | $785 | $798 |
| EBITDA | - | - | - | - | - |
| Net Income | $67 | $11 | -$34 | $57 | $54 |
| Diluted EPS | $0.13 | $0.02 | -$0.07 | $0.11 | $0.11 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $487 | $539 | $505 | $428 | $530 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $4,351 | $3,954 | $3,769 | $3,736 | $3,663 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$4 | - | - | $13 | - |
| Capital Expenditure | $65 | - | - | $51 | - |
| Free Cash Flow | -$69 | - | - | -$38 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 57.3% | 57.5% | 53.4% | 57.3% | 58.3% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 5.6% | 0.9% | -3.0% | 4.2% | 3.9% |
| FCF Margin | -5.8% | - | - | -2.8% | - |
| Diluted EPS Growth | - | - | - | - | - |
Get the ELAN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.